Skip to main content
SpringerLink
Log in

Methotrexate in juvenile rheumatoid arthritis

Evidence of age dependent pharmacokinetics

  • Pharmacokinetics and Disposition
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

Children with juvenile rheumatoid arthritis (JRA) have been reported to require higher doses (per kg body weight) of methotrexate (MTX) than adults with rheumatoid arthritis to control their disease. The purpose of the present study was to characterise the plasma pharmacokinetics of MTX and its major metabolite, 7-hydroxymethotrexate (7-OHMTX) in children, and to compare the results with those previously obtained in adults. Thirteen patients (age 5–16 y) with JRA (median disease duration 5.5 y) were studied after once weekly oral administration of MTX (median 0.21 mg·kg−1).

The analytical method was sufficiently sensitive to permit determination of plasma and urinary concentrations of MTX and 7-OHMTX during the entire dose interval in most of the patients.

The dose normalized area under the plasma concentration versus time-curve (AUC) of MTX increased with the age of the children and was lower than previously found in adults. The dose normalized AUC of 7-OHMTX was not dependent on age. No correlation was found between the AUCs of MTX and 7-OHMTX.

The results suggest that the age-dependence of the pharmacokinetics of MTX might explain the observation that at least some children require higher doses of MTX than adults to obtain a sufficient therapeutic effect.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. McBurney MW, Whitmore GF (1975) Mechanism of growth inhibition by methotrexate. Cancer Res 35: 586–590

    Google Scholar 

  2. Hryniuk W, Bertino JR (1971) Growth rate and cell kill. Ann NY, Acad Sci 186: 330–342

    Google Scholar 

  3. Skinner M, Schwartz R (1972) Immunosuppressive therapy. N Engl J Med 287: 221–227

    Google Scholar 

  4. Furst DE (1985) Clinical pharmacology of very low dose methotrexate for use in rheumatoid arthritis. J Rheumatol 12: 11–14

    Google Scholar 

  5. Furst DE, Kremer JM (1988) Methotrexate in rheumatoid arthritis. Arthritis Rheum 31: 305–314

    Google Scholar 

  6. Seideman P (1993) Methotrexate. The relationship between dose and clinical effect. Br J Rheumatol 32: 751–753

    Google Scholar 

  7. Shen DD, Azarnoff DL (1978) Clinical pharmacokinetics of methotrexate. Clin Pharmacokinet 3: 1–13

    Google Scholar 

  8. Edelman J, Biggs DF, Jamali F, Russell AS (1984) Low-dose methotrexate kinetics in arthritis. Clin Pharmacol Ther 35: 382–386

    Google Scholar 

  9. Sinnett MJ, Groff GD, Raddatz DA, Franck WA, Bertino JJ (1989) Methotrexate pharmacokinetics in patients with rheumatoid arthritis. J Rheumatol 16: 745–748

    Google Scholar 

  10. Herman RA, Pedersen-Veng P, Hoffman J, Koehnke R, Furst DE (1989) Pharmacokinetics of low-dose methotrexate in rheumatoid arthritis patients. J Pharm Sci 78: 165–171

    Google Scholar 

  11. Seideman P, Beck O, Eksborg S, Wennberg M (1993) The pharmacokinetics of methotrexate and its 7-hydroxy metabolite in patients with rheumatoid arthritis. Br J Clin Pharmacol 35: 409–412

    Google Scholar 

  12. Stewart CF, Fleming RA, Arkin CR, Evans WE (1990) Coadministration of naproxen and low-dose methotrexate in patients with rheumatoid arthritis. Clin Pharmacol Ther 47: 540–546

    Google Scholar 

  13. Stewart CF, Fleming RA, Germain BF, Seleznick MJ, Evans WE (1991) Aspirin alters methotrexate disposition in rheumatoid arthritis patients. Arthritis Rheum 34: 1514–1520

    Google Scholar 

  14. Evans WE, Crom WR, Sinkule JA, Yee GC, Stewart CF, Hutson PR (1983) Pharmacokinetics of anticancer drugs in children. Drug Metab Rev 14: 847–886

    Google Scholar 

  15. Evans WE, Schell MJ, Pui CH (1990) MTX clearance is more important for intermediate-risk ALL. J Clin Oncol 8: 1115–1116

    Google Scholar 

  16. Borsi JD, Sagen E, Romslo I, Moe PJ (1990) Pharmacokinetics of folinic acid in children with acute lymphoblastic leukemia. Haematol Bluttransfus 33: 118–121

    Google Scholar 

  17. Wallace CA, Sherry DD (1992) Preliminary report of higher dose methotrexate treatment in juvenile rheumatoid arthritis. J Rheumatol 19: 1604–1607

    Google Scholar 

  18. Rose C, Singsen B, Eichenfield A, Goldsmith D, Athreya B (1990) Safety and efficacy of methotrexate therapy for Juvenile rheumatoid arthritis. J Pediatr 177: 653–659

    Google Scholar 

  19. Giannini EH, Brewer EJ, Kuzmina N, Shaikov A, Maximov A, Vorontsov I, Fink CW, Newman AJ, Cassidy JT, Zemel LS (1992) Methotrexate in resistant juvenile rheumatoid arthritis. Results of the USA-USSR double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children's Study Group. N Engl J Med 326: 1043–1049

    CAS  PubMed  Google Scholar 

  20. Brewer E, Bass J, Baum J, Cassidy J, Fink C, Jacobs J, Hanson V, Levinson J, Schaller J, Stillman J (1977) Current proposed revision of JRA criteria. Arthritis Rheum 20 [Suppl]: 195–199

    PubMed  Google Scholar 

  21. Beck O, Seideman P, Wennberg M, Peterson C (1991) Trace analysis of methotrexate and 7-hydroxymethotrexate in human plasma and urine by a novel high-performance liquid chromatographic method. Ther Drug Monit 13: 528–532

    Google Scholar 

  22. Statistical Consultants I (1986) Pcnonlin and nonlin84: Software for statistical analysis of nonlinear models. The American Statistician 40: 52

    Google Scholar 

  23. Boxenbaum H, Riegelman S, Elashoff R (1974) Statistical estimation in pharmacokinetics. J Pharmacokinet Biopharm 2: 123–148

    Google Scholar 

  24. Daniel WW (1978) Applied nonparametric statistics. Houghton Mifflin Company Boston

    Google Scholar 

  25. Dallal G (1988) Pitman. A Fortran program for exact randomization tests. Comput Biomed Res 21: 9–15

    Google Scholar 

  26. Skoglund KA, Söderhäll S, Beck O, Peterson C, Wennberg M, Hayder S, Björk O (1994) Plasma and urine levels of methotrexate and 7-hydroxymethotrexate in children with ALL during maintenance therapy with weekly oral methotrexate. Med Pediatr Oncol 22: 187–193

    Google Scholar 

  27. Wallace CA, Bleyer WA, Sherry DD, Salmonson KL, Wedgwood RJ (1989) Toxicity and serum levels of methotrexate in children with juvenile rheumatoid arthritis. Arthritis Rheum 32: 677–681

    CAS  PubMed  Google Scholar 

  28. Balis FM, Savitch JL, Bleyer WA (1983) Pharmacokinetics of oral methotrexate in children. Cancer Res 43: 2342–2345

    Google Scholar 

  29. Pinkerton CR, Welshman SG, Glasgow JF, Bridges JM (1980) Can food influence the absorption of methotrexate in children with acute lymphoblastic leukaemia? Lancet II: 944–946

    Google Scholar 

  30. Oguey D, Kölliker F, Gerber NJ, Reichen J (1992) Effect of food on the bioavailability of low-dose methotrexate in patients with rheumatoid arthritis. Arthritis Rheum, 35: 611–614

    Google Scholar 

  31. Ravelli A, Di Fucci G, Molinaro M, Ramenghi B, Zonta L, Regazzi M, Martini A (1993) Plasma levels after oral methotrexate in children with juvenile rheumatoid arthritis. J Rheumatol 20: 1573–1577

    Google Scholar 

  32. Evans WE, Crom WR, Stewart CF, Bowman WP, Chen CH, Abromowitch M, Simone JV (1984) Methotrexate systemic clearance influences probability of relapse in children with standard-risk acute lymphocytic leukaemia. Lancet I: 359–362

    Google Scholar 

  33. Borsi JD, Moe PJ (1987) Systemic clearance of methotrexate in the prognosis of acute lymphoblastic leukemia in children. Cancer 60: 3020–3024

    Google Scholar 

  34. Donelli MG, Zucchetti M, Masera G, DÍncalci M, Robatto A, Rossi MR (1993) Pharmacokinetis of HD-MTX (5 g i.v. sq.m) in infants, children and adolescents with non B-acute lymphoblastic leukemia. Proc ASCO 12: 150

    Google Scholar 

  35. Najjar TA, Alfawaz IM (1993) Pharmacokinetics of methotrexate in children with acut lymphocytic leukemia. Chemotherapy 39: 242–247

    Google Scholar 

  36. Koren G, Gorodischer R (1992) Digoxin. In: Aranda J (ed) Pediatric pharmacology. Therapeutic principales in practice. Saunders, Philadelphia, pp 355–364

    Google Scholar 

  37. Jalling B, Boréus L, Rane A, Sjöqvist F (1970) Plasma concentrations of diphenylhydantoin in young infants. Pharmacol Clin 2: 2000–2002

    Google Scholar 

  38. Seideman P, Albertioni F, Beck O, Eksborg S, Peterson C (1994) Chloroquine reduces bioavailability of methotrexate in patients with rheumatoid arthritis — a possible mechanism for reduced hepatotoxicity. Arthritis Rheum 37: 830–833

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Pharmacology, Karolinska Hospital, S-17176, Stockholm, Sweden

    F. Albertioni, O. Beck & C. Peterson

  2. Oslo Sanitetsforening Rheumatism Hospital, Oslo, Norway

    B. Flatø & O. Vinje

  3. Department of Internal Medicine, Division of Rheumatology, Karolinska Institute Danderyd Hospital, Stockholm, Sweden

    P. Seideman

  4. Karolinska Pharmacy, Stockholm, Sweden

    S. Eksborg

Authors
  1. F. Albertioni
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. O. Beck
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Peterson
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. B. Flatø
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. O. Vinje
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S. Eksborg
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. P. Seideman
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Albertioni, F., Beck, O., Peterson, C. et al. Methotrexate in juvenile rheumatoid arthritis. Eur J Clin Pharmacol 47, 507–511 (1995). https://doi.org/10.1007/BF00193703

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00193703

Key words

Search

Navigation